RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cash from investing

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥608.6B
P/E ratio
18.2x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2025-89,170+446.49%
Mar 31, 2024-16,317+23.84%
Mar 31, 2023-13,176-19.69%
Mar 31, 2022-16,406+60.26%
Mar 31, 2021-10,237+8.85%
Mar 31, 2020-9,405-8.20%
Mar 31, 2019-10,245-6.98%
Mar 31, 2018-11,014+15.80%
Mar 31, 2017-9,511+56.79%
Mar 31, 2016-6,066-32.78%
Mar 31, 2015-9,024

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)